210 related articles for article (PubMed ID: 20664280)
1. Observational study of the safety of an ultra-rush sublingual immunotherapy regimen to treat rhinitis due to house dust mites.
Roger A; Justicia JL; Navarro LÁ; Eseverri JL; Ferrès J; Malet A; Alvà V
Int Arch Allergy Immunol; 2011; 154(1):69-75. PubMed ID: 20664280
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
[TBL] [Abstract][Full Text] [Related]
3. [Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis].
Du X; Shu C; Xu G; Ma M; Song H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):372-3. PubMed ID: 22730824
[TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.
Yonekura S; Okamoto Y; Sakurai D; Horiguchi S; Hanazawa T; Nakano A; Kudou F; Nakamaru Y; Honda K; Hoshioka A; Shimojo N; Kohno Y
Allergol Int; 2010 Dec; 59(4):381-8. PubMed ID: 20864799
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice.
Ferrés J; Justicia JL; García MP; Muñoz-Tudurí M; Alvà V
Allergol Immunopathol (Madr); 2011; 39(3):122-7. PubMed ID: 20570032
[TBL] [Abstract][Full Text] [Related]
6. Safety, tolerability and clinical efficacy of ultra-rush sublingual immunotherapy among patients suffering from allergic rhinitis.
Balaji R; Parasuramalu BG; Chandregowda BV; Gangaboraiah
Allergol Immunopathol (Madr); 2014; 42(3):216-23. PubMed ID: 23481554
[
